$
3.45
11:09 PM EST
New Key Statistics Module, Z-Score and F-Score
OTCPK:CSPCY Key Ratios
Market Cap $ M | 10,001.45 |
Enterprise Value $ M | 8,785.09 |
P/E(ttm) | 12.52 |
PE Ratio without NRI | 12.52 |
Forward PE Ratio | 11.06 |
Price/Book | 2.13 |
Price/Sales | 2.34 |
Price/Free Cash Flow | 32.27 |
Price/Owner Earnings | 24.67 |
Payout Ratio % | 0.26 |
Revenue (TTM) $ M | 4,418.00 |
EPS (TTM) $ | 0.28 |
Beneish M-Score | -1.91 |
10-y EBITDA Growth Rate % | 18.70 |
5-y EBITDA Growth Rate % | 14.10 |
y-y EBITDA Growth Rate % | -29.10 |
EV-to-EBIT | 8.28 |
EV-to-EBITDA | 8.28 |
PEG | 0.89 |
Shares Outstanding M | 2,898.97 |
Net Margin (%) | 18.66 |
Operating Margin % | 22.30 |
Pre-tax Margin (%) | 23.48 |
Quick Ratio | 2.22 |
Current Ratio | 2.54 |
ROA % (ttm) | 12.92 |
ROE % (ttm) | 17.83 |
ROIC % (ttm) | 23.53 |
Dividend Yield % | 4.15 |
Altman Z-Score | 5.87 |
CSPCY Number of Guru Trades
CSPCY Volume of Guru Trades
Gurus Latest Trades with OTCPK:CSPCY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:CSPCY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
CSPC Pharmaceutical Group Ltd Insider Transactions
No Available Data
News about OTCPK:CSPCY
Total 0- 1